New Enterprise Associates related stories
All articles and analysis
peHUB Wire: Tuesday, September 22, 2009Random Ramblings
- peHUB Wire: Tuesday, September 22, 2009
Random Ramblings
- Exit watch, week of Sept. 21, 2009
News briefs about Evalve and other VC-backed companies bought in the past week
- Without a lot of VC, startups get by
Startups say they face a dry financial climate, forcing them to turn to funding alternatives
- Startups Get Schooled At TechCrunch Conference
One of the most interesting part of going to TechCrunch 50 this week, at least for me, was listening to seasoned investors ask tough questions of young, inexperienced entrepreneurs. “Mike (Arrington, of TechCrunch) said I was harsh,” Y Combinator co-founder Paul Graham told TechCrunch writer Sarah Lacy after his panel, sounding surprised. “What I want to know is, how does it all work? What’s the insides? “You have to ask a lot of questions, and people never seem to answer all of them. When you’re asking people a whole bunch of questions, you seem mean. I wasn’t sure whether we were supposed to act like we really meant it.”
- peHUB Wire: Thursday, September 17, 2009
Random Ramblings
- peHUB Wire: Thursday, September 17, 2009
Random Ramblings
- Abbott Buying Evalve for Up To $410 Million
Abbott (NYSE: ABT) has agreed to acquire Evalve Inc., a Menlo Park, Calif.-based provider of devices for minimally invasive repair of cardiac mitral valves. The deal includes a $320 million up-front payment, plus another $90 million in possible earnouts. Evalve has raised over $100 million in VC funding from firms like ABS Ventures, Abbott Labs, Delphi Ventures, New Enterprise Associates and Split Rock Partners.